- Home
- XFOR vs SI Comparison
XFOR vs SI Comparison
Compare XFOR & SI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XFOR | SI |
|---|---|---|
| Founded | 2014 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 377.3M | 435.3M |
| IPO Year | 2017 | 2025 |
Fundamental Metrics
Financial Performance| Metric | XFOR | SI |
|---|---|---|
| Price | $4.04 | $21.29 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $9.00 | ★ $20.80 |
| AVG Volume (30 Days) | ★ 669.6K | 115.9K |
| Earning Date | 05-04-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 98.08 |
| EPS | ★ N/A | N/A |
| Revenue | $6,500,000.00 | ★ $47,317,000.00 |
| Revenue This Year | N/A | $39.59 |
| Revenue Next Year | N/A | $31.37 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 150.00 | 49.63 |
| 52 Week Low | $2.80 | $10.92 |
| 52 Week High | $4.83 | $24.60 |
Technical Indicators
Market Signals| Indicator | XFOR | SI |
|---|---|---|
| Relative Strength Index (RSI) | 50.77 | 49.69 |
| Support Level | $3.58 | $13.07 |
| Resistance Level | $4.48 | $23.08 |
| Average True Range (ATR) | 0.21 | 1.28 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 35.25 | 57.60 |
Price Performance
Historical ComparisonAbout XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
About SI Shoulder Innovations Inc.
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System. Geographically, the company operates in United States and are planning to expand.